HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mechanism of the induction of the differentiation of HL-60 leukemia cells by antifolates.

Abstract
The classic inhibitor of dihydrofolate reductase (DHFR), methotrexate (MTX), has been shown to be an effective inducer of the differentiation of HL-60 promyelocytic leukemia cells (Bodner A.J. et al.; J. Natl. Cancer Inst. 67:1025-1030; 1981). We have obtained evidence that induction of the differentiation of these cells by MTX, as well as by other folic acid antagonists, is the result of the effects of these agents on purine and thymine nucleotide biosynthesis. Thymidine (10 microM) completely blocked both the cytotoxicity and induction of differentiation produced by the specific inhibitor of thymidylate synthase (TS), N10-propargyl-5,8-dideazafolic acid (CB-3717). Thymidine also blocked the acute cytotoxicity caused by MTX and trimetrexate (TMQ); the induction of differentiation and the loss of proliferative capacity, however, were only partially prevented by thymidine. Hypoxanthine (100 microM), which completely restored antifolate-depleted purine nucleotide levels, had no effect on either the cytotoxicity or the induction of maturation produced by these agents. The growth inhibitory effects and the induction of differentiation caused by dideazatetrahydrofolic acid (DDATHF), which acts on de novo purine nucleotide biosynthesis rather than on DHFR or TS, was completely prevented by hypoxanthine. Hypoxanthine also completely prevented the inhibition of cellular replication and induction of differentiation by MTX and TMQ when combined with thymidine. The findings suggest that the depletion of intracellular thymine nucleotide levels by the antifolates, MTX, TMQ, and CB-3717 is the primary event involved in the maturation of HL-60 leukemia cells produced by these agents and that maturation occurs concomitantly with a high level of cytotoxicity.(ABSTRACT TRUNCATED AT 250 WORDS)
AuthorsJ A Sokoloski, G P Beardsley, A C Sartorelli
JournalCancer communications (Cancer Commun) Vol. 1 Issue 3 Pg. 199-207 ( 1989) ISSN: 0955-3541 [Print] United States
PMID2700913 (Publication Type: Case Reports, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibodies, Monoclonal
  • Folic Acid Antagonists
  • Ribonucleotides
  • Tretinoin
  • Tetradecanoylphorbol Acetate
  • Thymidine
  • Dimethyl Sulfoxide
Topics
  • Antibodies, Monoclonal
  • Cell Differentiation (drug effects)
  • Cell Division (drug effects)
  • Cell Line
  • DNA Replication (drug effects)
  • Dimethyl Sulfoxide (pharmacology)
  • Flow Cytometry
  • Fluorescent Antibody Technique
  • Folic Acid Antagonists (pharmacology)
  • Humans
  • Kinetics
  • Leukemia, Promyelocytic, Acute
  • Ribonucleotides (metabolism)
  • Structure-Activity Relationship
  • Tetradecanoylphorbol Acetate (pharmacology)
  • Thymidine (metabolism)
  • Tretinoin (pharmacology)
  • Tumor Cells, Cultured (cytology, drug effects, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: